GSK plc (GLAXF)

USD 17.26

(-0.4%)

Gross Profit Summary of GSK plc

  • GSK plc's latest annual gross profit in 2023 was 21.25 Billion GBP , up 7.5% from previous year.
  • GSK plc's latest quarterly gross profit in 2024 Q1 was 5.42 Billion GBP , down -5.04% from previous quarter.
  • GSK plc reported a annual gross profit of 19.77 Billion GBP in annual gross profit 2022, down -12.18% from previous year.
  • GSK plc reported a annual gross profit of 22.51 Billion GBP in annual gross profit 2021, up 0.52% from previous year.
  • GSK plc reported a quarterly gross profit of 5.42 Billion GBP for 2024 Q1, down -5.04% from previous quarter.
  • GSK plc reported a quarterly gross profit of 5.61 Billion GBP for 2024 Q3, down -3.24% from previous quarter.

Annual Gross Profit Chart of GSK plc (2023 - 1989)

Historical Annual Gross Profit of GSK plc (2023 - 1989)

Year Gross Profit Gross Profit Growth
2023 21.25 Billion GBP 7.5%
2022 19.77 Billion GBP -12.18%
2021 22.51 Billion GBP 0.52%
2020 22.39 Billion GBP 2.3%
2019 21.89 Billion GBP 6.37%
2018 20.58 Billion GBP 3.71%
2017 19.84 Billion GBP 6.69%
2016 18.59 Billion GBP 23.42%
2015 15.07 Billion GBP -3.91%
2014 15.68 Billion GBP -12.48%
2013 17.92 Billion GBP -3.33%
2012 18.53 Billion GBP -7.57%
2011 20.05 Billion GBP -3.58%
2010 20.8 Billion GBP -0.9%
2009 20.98 Billion GBP 17.01%
2008 17.93 Billion GBP 2.44%
2007 17.51 Billion GBP -3.87%
2006 18.21 Billion GBP 7.81%
2005 16.89 Billion GBP 8.13%
2004 15.62 Billion GBP -7.52%
2003 16.89 Billion GBP 1.77%
2002 16.6 Billion GBP 3.16%
2001 16.09 Billion GBP 14.01%
2000 14.11 Billion GBP 239.68%
1999 4.15 Billion GBP -35.45%
1998 6.43 Billion GBP -19.32%
1997 7.98 Billion GBP -4.33%
1996 8.34 Billion GBP -20.49%
1995 10.49 Billion GBP 85.47%
1994 5.65 Billion GBP 14.73%
1993 4.93 Billion GBP 20.36%
1992 4.09 Billion GBP 20.58%
1991 3.39 Billion GBP 6.86%
1990 3.17 Billion GBP 23.7%
1989 2.57 Billion GBP 24.82%

Peer Gross Profit Comparison of GSK plc

Name Gross Profit Gross Profit Difference
AstraZeneca PLC 34.69 Billion USD 38.743%
Bristol-Myers Squibb Company PFD CONV 2 34.31 Billion USD 38.064%
CSPC Pharmaceutical Group Limited 30.13 Billion USD 29.485%
Clarus Therapeutics Holdings, Inc. 11.23 Million USD -189025.211%
Novartis AG 34.18 Billion USD 37.838%
PT Kalbe Farma Tbk. 743.47 Million USD -2758.476%